NextCure, Inc. (NXTC)
USD 0.29
(7.48%)
USD 0.29
(7.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -52.97 Million | -53.88 Million | -57.24 Million | -44.95 Million | -35.62 Million | 7.99 Million |
| Net Income | -62.72 Million | -74.73 Million | -69.38 Million | -36.6 Million | -33.73 Million | -22.79 Million |
| Depreciation & Amortization | 3.68 Million | 4.12 Million | 7.19 Million | 3.41 Million | 2.68 Million | 1.67 Million |
| Deferred income taxes | -17.49 Million | - | -23.74 Million | -12.69 Million | -7.26 Million | - |
| Stock-based compensation | 8.18 Million | 9.5 Million | 10.28 Million | 7.91 Million | 1.88 Million | 263 Thousand |
| Change in working capital | -1.94 Million | 3.72 Million | -5.33 Million | -19.67 Million | -6.46 Million | 28.85 Million |
| Other non-cash items | 17.31 Million | 3.49 Million | 23.74 Million | 12.69 Million | 7.26 Million | 3.2 Million |
| Investing Cash Flow | 39.27 Million | 67.97 Million | 36.6 Million | 43.52 Million | -303.92 Million | -3.06 Million |
| Investments in PPE | -820 Thousand | -2.11 Million | -2.36 Million | -7.13 Million | -3.37 Million | -3.06 Million |
| Acquisitions | -40.09 Thousand | -70.09 Thousand | -38.96 Thousand | -50.65 Thousand | - | - |
| Investment purchases | -73.5 Million | -34.64 Million | -156.47 Million | -137.12 Million | -300.55 Million | - |
| Sales/Maturities of investments | 113.59 Million | 104.73 Million | 195.43 Million | 187.78 Million | - | - |
| Other Investing Activities | 40.09 Thousand | 70.09 Thousand | 38.96 Thousand | 50.65 Thousand | -300.55 Thousand | - |
| Financing Cash Flow | 154 Thousand | 200 Thousand | -3.26 Million | -1.41 Million | 243.04 Million | 121.41 Million |
| Debt repayment | - | - | -3.47 Million | -1.52 Million | -4.54 Million | -400 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 154 Thousand | 66 Thousand | 208 Thousand | 112 Thousand | 238.5 Million | 4000.00 |
| Other Financing Activities | 154 Thousand | 134 Thousand | -3265.00 | -1415.00 | 9.08 Million | 121.81 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.94 Million | 2.32 Million | -1.95 Million | 2.04 Million | -622 Thousand | 1.34 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.94 Million | 1.39 Million | -3.38 Million | -21.71 Million | -5.83 Million | 27.5 Million |
| Cash at beginning of period | 26.63 Million | 12.33 Million | 36.28 Million | 39.13 Million | 135.63 Million | 9.28 Million |
| Cash at end of period | 13.08 Million | 26.63 Million | 12.37 Million | 36.28 Million | 39.13 Million | 135.63 Million |
| Capital Expenditure | -820 Thousand | -2.11 Million | -2.36 Million | -7.13 Million | -3.37 Million | -3.06 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -13.54 Million | 14.29 Million | -23.9 Million | -2.84 Million | -96.5 Million | 126.34 Million |
| Free Cash Flow | -53.79 Million | -56 Million | -59.6 Million | -52.08 Million | -38.99 Million | 4.92 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.4 Million | -17.1 Million | -14.46 Million | -62.72 Million | -14.3 Million | -17.85 Million |
| Depreciation & Amortization | 701 Thousand | 940 Thousand | 824 Thousand | 3.68 Million | 946 Thousand | 954 Thousand |
| Deferred income taxes | - | - | -3.9 Million | -17.49 Million | -318 Thousand | -196 Thousand |
| Stock-based compensation | 1.59 Million | 1.69 Million | 1.98 Million | 8.18 Million | 2 Million | 2.12 Million |
| Change in working capital | 3.51 Million | 385 Thousand | 1.16 Million | -1.94 Million | -1.25 Million | 97 Thousand |
| Other non-cash items | 2.23 Million | 2.89 Million | 3.72 Million | 17.31 Million | 144 Thousand | 132 Thousand |
| Investing Cash Flow | 12.16 Million | 17.88 Million | 4.16 Million | 39.27 Million | 10.27 Million | 6.71 Million |
| Investments in PPE | -301 Thousand | -37 Thousand | -13 Thousand | -820 Thousand | -279 Thousand | -280 Thousand |
| Acquisitions | - | - | -4175.00 | -40.09 Thousand | - | -6990.00 |
| Investment purchases | -22.44 Million | -11.13 Million | -11.81 Million | -73.5 Million | - | -30.28 Million |
| Sales/Maturities of investments | 34.9 Million | 29.05 Million | 15.99 Million | 113.59 Million | 10.55 Million | 37.27 Million |
| Other Investing Activities | 12.46 Thousand | 17.91 Thousand | 4175.00 | 40.09 Thousand | 10.55 Thousand | 6990.00 |
| Financing Cash Flow | 106 Thousand | 1000.00 | 71 Thousand | 154 Thousand | - | 83 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 106 Thousand | 1000.00 | 71 Thousand | 154 Thousand | - | 83 Thousand |
| Other Financing Activities | 106.00 | 1.00 | 71.00 | 154 Thousand | - | 83.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 584 Thousand | 2.16 Million | -272 Thousand | -1.94 Million | -211 Thousand | 894 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.92 Million | -1.77 Million | 1.43 Million | 1.94 Million | -1.03 Million | -797 Thousand |
| Cash at beginning of period | 18.35 Million | 13.08 Million | 19.51 Million | 26.63 Million | 22.01 Million | 29.97 Million |
| Cash at end of period | 20.84 Million | 18.35 Million | 13.08 Million | 13.08 Million | 19.51 Million | 22.01 Million |
| Capital Expenditure | -301 Thousand | -37 Thousand | -13 Thousand | -820 Thousand | -279 Thousand | -280 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.49 Million | 5.27 Million | -6.43 Million | -13.54 Million | -2.5 Million | -7.95 Million |
| Free Cash Flow | -10.07 Million | -12.64 Million | -10.68 Million | -53.79 Million | -13.05 Million | -15.02 Million |
ADRZF
0LSZ
009830
RAW
MYFW
ART